MyoVista Measurements in Patients With Atherosclerosis and CAD

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

September 22, 2019

Study Completion Date

February 22, 2020

Conditions
Coronary Artery Disease (CAD)Atherosclerosis
Interventions
DEVICE

MyoVista

The clinical set up of MyoVista™ is identical to that of a traditional 12-lead ECG but it obtains and processes signal information in a way that permits much greater resolution of the electrical activity associated with the myocardium MyoVista.

Trial Locations (1)

90502

Los Angeles Biomedical Research Institute, Torrance

Sponsors
All Listed Sponsors
collaborator

Heart Test Laboratories, Inc.

INDUSTRY

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER